View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
  • 2 Magyar Tudományos Akadémia–Semmelweis Egyetem Gasztroenterológiai és Endokrinológiai Kutatócsoport Budapest
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A protonpumpagátlók (protonpumpa-inhibitorok, PPI) bevezetése új fejezetet nyitott a gastrooesophagealis refluxbetegség (gastroesophageal reflux disease, GERD) kezelésében. A betegek kisebb, de nem jelentéktelen hányadában azonban a PPI sem hatékony. Ilyen esetekben az első kérdés mindig az, hogy a tünetek valóban GERD-nek tulajdoníthatók-e, vagy egyéb betegség után kell kutatnunk. Ha a GERD a legvalószínűbb lehetőség, akkor a további vizsgálatok és a több támadáspontú kezelés előtt fel kell térképeznünk a beteg együttműködését (compliance). Ha az eredménytelen PPI-kezelés hátterében nem helytelenül kezelt GERD áll, akkor számos egyéb kórkép lehetőségét is fel kell vetnünk. Összefoglaló közleményünkben az elkülönítő diagnosztikai kérdésekről adunk áttekintést.

  • Kahrilas, P. J.: When proton pump inhibitors fail. Clin. Gastroenterol. Hepatol., 2008, 6 , 482–483.

    Kahrilas P. J. , 'When proton pump inhibitors fail ' (2008 ) 6 Clin. Gastroenterol. Hepatol. : 482 -483.

    • Search Google Scholar
  • Fass, R.: Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs, 2007, 67 , 1521–1530.

    Fass R. , 'Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure ' (2007 ) 67 Drugs : 1521 -1530.

    • Search Google Scholar
  • Bredenoord, A. J., Smout, A. J.: Refractory gastrooesophageal reflux disease. Eur. J. Gastroenterol. Hepatol., 2008, 20 , 217–223.

    Smout A. J. , 'Refractory gastrooesophageal reflux disease ' (2008 ) 20 Eur. J. Gastroenterol. Hepatol. : 217 -223.

    • Search Google Scholar
  • Inadomi, J. M., McIntyre, L., Bernard, L. és mtsai: Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am. J. Gastroenterol., 2003, 98 , 1940–1944.

    Bernard L. , 'Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs ' (2003 ) 98 Am. J. Gastroenterol. : 1940 -1944.

    • Search Google Scholar
  • Fass, R., Shapiro, M., Dekel, R. és mtsai: Proton pump inhibitor failure in reflux disease: where next? Aliment. Pharmacol. Ther., 2005, 22 , 79–94.

    Dekel R. , 'Proton pump inhibitor failure in reflux disease: where next? ' (2005 ) 22 Aliment. Pharmacol. Ther. : 79 -94.

    • Search Google Scholar
  • Vaezi, M. F.: ‘Refractory GERD’: acid, nonacid, or not GERD? Am. J. Gastroenterol., 2004, 99 , 989–990.

    Vaezi M. F. , '‘Refractory GERD’: acid, nonacid, or not GERD? ' (2004 ) 99 Am. J. Gastroenterol. : 989 -990.

    • Search Google Scholar
  • Fass, R., Murthy, U., Hayden, C. W. és mtsai: Omeprazole 40 mg once a day in low-intensity intra-oesophageal stimuli induce symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy: a prospective, randomized, multi-centre study. Aliment. Pharmacol. Ther., 2000, 14 , 1595–1603.

    Hayden C. W. , 'Omeprazole 40 mg once a day in low-intensity intra-oesophageal stimuli induce symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy: a prospective, randomized, multi-centre study ' (2000 ) 14 Aliment. Pharmacol. Ther. : 1595 -1603.

    • Search Google Scholar
  • Hatlebakk, J. G., Berstad, A.: Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole. Aliment. Pharmacol. Ther., 1997, 11 , 1093–1099.

    Berstad A. , 'Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole ' (1997 ) 11 Aliment. Pharmacol. Ther. : 1093 -1099.

    • Search Google Scholar
  • Martinez, S. D., Malagon, I. B., Garewal, H. S. és mtsai: Non-erosive reflux disease (NERD): acid reflux and symptom patterns. Aliment. Pharmacol. Ther., 2003, 17 , 537–545.

    Garewal H. S. , 'Non-erosive reflux disease (NERD): acid reflux and symptom patterns ' (2003 ) 17 Aliment. Pharmacol. Ther. : 537 -545.

    • Search Google Scholar
  • Dean, B. B., Gano, A. D. Jr., Knight, K. és mtsai: Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin. Gastroenterol. Hepatol., 2004, 2 , 656–664.

    Knight K. , 'Effectiveness of proton pump inhibitors in nonerosive reflux disease ' (2004 ) 2 Clin. Gastroenterol. Hepatol. : 656 -664.

    • Search Google Scholar
  • Lind, T., Havelund, T., Carlsson, R. és mtsai: Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand. J. Gastroenterol., 1997, 32 , 974–979.

    Carlsson R. , 'Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response ' (1997 ) 32 Scand. J. Gastroenterol. : 974 -979.

    • Search Google Scholar
  • Gallup Study of Consumers’ use of Stomach Relief Products. Princeton (NJ): The Gallup Organization, 2000.

  • Tack, J., Talley, N. J., Camilleri, M. és mtsai: Functional gastroduodenal disorders. Gastroenterology, 2006, 130 , 1466–1479.

    Camilleri M. , 'Functional gastroduodenal disorders ' (2006 ) 130 Gastroenterology : 1466 -1479.

    • Search Google Scholar
  • Delaney, B., Ford, A. C., Forman, D. és mtsai: Initial management strategies for dyspepsia. Cochrane Database Syst. Rev., 2005, 19 , CD001961.

    Forman D. , 'Initial management strategies for dyspepsia ' (2005 ) 19 Cochrane Database Syst. Rev. : CD001961 -.

    • Search Google Scholar
  • Frazzoni, M., De Micheli, E., Zentilin, P. és mtsai: Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment. Pharmacol. Ther., 2004, 20 , 81–88.

    Zentilin P. , 'Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn ' (2004 ) 20 Aliment. Pharmacol. Ther. : 81 -88.

    • Search Google Scholar
  • Watson, R. G., Tham, T. C., Johnston, B. T. és mtsai: Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: the „sensitive oesophagus”. Gut, 1997, 40 , 587–590.

    Johnston B. T. , 'Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux: the „sensitive oesophagus” ' (1997 ) 40 Gut : 587 -590.

    • Search Google Scholar
  • Fass, R., Ofman, J. J.: Gastroesophageal reflux disease: should we adopt a new conceptual framework? Am. J. Gastroenterol., 2002, 97 , 1901–1909.

    Ofman J. J. , 'Gastroesophageal reflux disease: should we adopt a new conceptual framework? ' (2002 ) 97 Am. J. Gastroenterol. : 1901 -1909.

    • Search Google Scholar
  • Hobson, A. R., Matthews, P., Furlong, P. és mtsai: The role of esophageal afferent pathway sensitivity in non-erosive reflux disease [abstract no. 128]. Gastroenterology, 2004, 126 (4 Suppl. 2) , A18.

    Furlong P. , 'The role of esophageal afferent pathway sensitivity in non-erosive reflux disease [abstract no. 128] ' (2004 ) 126 Gastroenterology : A18 -.

    • Search Google Scholar
  • Shapiro, M., Green, C., Bautista, J. és mtsai: Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am. J. Gastroenterol., 2006, 101 , 1084–1091.

    Bautista J. , 'Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid ' (2006 ) 101 Am. J. Gastroenterol. : 1084 -1091.

    • Search Google Scholar
  • Mainie, I., Tutuian, R., Shay, S. és mtsai: Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut, 2006, 55 , 1398–4402.

    Shay S. , 'Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring ' (2006 ) 55 Gut : 1398 -4402.

    • Search Google Scholar
  • Vela, M., Camacho-Lobato, L., Srinivasan, R. és mtsai: Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology, 2001, 120 , 1599–1606.

    Srinivasan R. , 'Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole ' (2001 ) 120 Gastroenterology : 1599 -1606.

    • Search Google Scholar
  • Tutuian, R., Castell, D. O.: Rumination documented by using combined multichannel intraluminal impedance and manometry. Clin. Gastroenterol. Hepatol., 2004, 2 , 340–343.

    Castell D. O. , 'Rumination documented by using combined multichannel intraluminal impedance and manometry ' (2004 ) 2 Clin. Gastroenterol. Hepatol. : 340 -343.

    • Search Google Scholar
  • Chitkara, D. K., Bredenoord, A. J., Rucker, M. J. és mtsa: Aerophagia in adults: a comparison with functional dyspepsia. Aliment. Pharmacol. Ther., 2005, 22 , 855–858.

    Rucker M. J. , 'Aerophagia in adults: a comparison with functional dyspepsia ' (2005 ) 22 Aliment. Pharmacol. Ther. : 855 -858.

    • Search Google Scholar
  • Katz, P. O., Dalton, C. B., Richter, J. E. és mtsai: Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years’ experience with 1161 patients. Ann. Intern. Med., 1987, 106 , 593–597.

    Richter J. E. , 'Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years’ experience with 1161 patients ' (1987 ) 106 Ann. Intern. Med. : 593 -597.

    • Search Google Scholar
  • Vaezi, M. F.: Duodenogastroesophageal reflux. In: The oesophagus. Szerk.: Castro D., Richter J. Philadelphia (PA): Lippincott Williams & Wilkins, 2004, 1553–1538.

    Vaezi M. F. , '', in The oesophagus , (2004 ) -.

  • Netzer, P., Gut, A., Brundler, R. és mtsai: Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment. Pharmacol. Ther., 2001, 15 , 1375–1384.

    Brundler R. , 'Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis ' (2001 ) 15 Aliment. Pharmacol. Ther. : 1375 -1384.

    • Search Google Scholar
  • Marshall, R. E., Anggiansah, A., Manifold, D. K. és mtsai: Effect of omeprazole 20 mg twice daily on duodenogastric and gastrooesophageal bile reflux in Barrett’s oesophagus. Gut, 1998, 43 , 603–606.

    Manifold D. K. , 'Effect of omeprazole 20 mg twice daily on duodenogastric and gastrooesophageal bile reflux in Barrett’s oesophagus ' (1998 ) 43 Gut : 603 -606.

    • Search Google Scholar
  • Tack, J., Koek, G., Demedts, I. és mtsai: Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s esophagus: acid reflux, bile reflux, or both? Am. J. Gastroenterol., 2004, 99 , 981–988.

    Demedts I. , 'Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s esophagus: acid reflux, bile reflux, or both? ' (2004 ) 99 Am. J. Gastroenterol. : 981 -988.

    • Search Google Scholar
  • Siddiqui, A., Rodriguez-Stanley, S., Zubaidi, S. és mtsai: Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig. Dis. Sci., 2005, 50 , 81–85.

    Zubaidi S. , 'Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects ' (2005 ) 50 Dig. Dis. Sci. : 81 -85.

    • Search Google Scholar
  • Kudara, N., Chiba, T., Orii, S. és mtsai: Gastric emptying of patients with persistent reflux symptoms and erosive esophagitis under PPI therapy [abstract no. 23]. Neurogastroenterol. Motil., 2004, 16 , 654.

    Orii S. , 'Gastric emptying of patients with persistent reflux symptoms and erosive esophagitis under PPI therapy [abstract no. 23] ' (2004 ) 16 Neurogastroenterol. Motil. : 654 -.

    • Search Google Scholar
  • Sotoudehmanesh, R., Ali Asgari, A., Ansari, R. és mtsai: Endoscopic findings in end-stage renal disease. Endoscopy, 2003, 35 , 1467–1471.

    Ansari R. , 'Endoscopic findings in end-stage renal disease ' (2003 ) 35 Endoscopy : 1467 -1471.

    • Search Google Scholar
  • Liacouras, C. A., Campbell, C., Ruchelli, E. és mtsai: Eosinophilic esophagitis: a 10-year experience in 381 children. Clin. Gastroenterol. Hepatol., 2005, 3 , 1198–1206.

    Ruchelli E. , 'Eosinophilic esophagitis: a 10-year experience in 381 children ' (2005 ) 3 Clin. Gastroenterol. Hepatol. : 1198 -1206.

    • Search Google Scholar
  • Remedios, M., Campbell, C., Jones, D. M. és mtsai: Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone proprionate. Gastrointest. Endosc., 2006, 63 , 3–12.

    Jones D. M. , 'Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone proprionate ' (2006 ) 63 Gastrointest. Endosc. : 3 -12.

    • Search Google Scholar
  • Lucendo, A. J., Castillo, P., Martín-Chávarri, S. és mtsai: Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur. J. Gastroenterol. Hepatol., 2007, 19 , 417–424.

    Martín-Chávarri S. , 'Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases ' (2007 ) 19 Eur. J. Gastroenterol. Hepatol. : 417 -424.

    • Search Google Scholar
  • Johnston, B. T., Lewis, S., Collins, J. és mtsai: Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors. Scand. J. Gastroenterol., 1995, 30 , 1–5.

    Collins J. , 'Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors ' (1995 ) 30 Scand. J. Gastroenterol. : 1 -5.

    • Search Google Scholar
  • Nojkov, B., Chey, W., Adlis, S. és mtsai: Predictors of response to PPI therapy in patients with GERD: the influence of co-morbid IBS and psychological disease [abstract]. Gastroenterology, 2005, 128 (4 Suppl. 2) , A61.

    Adlis S. , 'Predictors of response to PPI therapy in patients with GERD: the influence of co-morbid IBS and psychological disease [abstract] ' (2005 ) 128 Gastroenterology : A61 -.

    • Search Google Scholar
  • Delhotal-Landes, B., Cournot, A., Vermerie, N. és mtsai: The effect of food and antacids on lansoprazole absorption and disposition. Eur. J. Drug Metab. Pharmacokinet., 1991, 3 , 315–320.

    Vermerie N. , 'The effect of food and antacids on lansoprazole absorption and disposition ' (1991 ) 3 Eur. J. Drug Metab. Pharmacokinet. : 315 -320.

    • Search Google Scholar
  • Furuta, T., Shirai, N., Watanabe, F. és mtsai: Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin. Pharmacol. Ther., 2002, 72 , 453–460.

    Watanabe F. , 'Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole ' (2002 ) 72 Clin. Pharmacol. Ther. : 453 -460.

    • Search Google Scholar
  • Holtmann, G., Cain, C., Malfertheiner, P.: Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology, 1999, 117 , 11–16.

    Malfertheiner P. , 'Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole ' (1999 ) 117 Gastroenterology : 11 -16.

    • Search Google Scholar
  • Egan, L. J., Myhre, G. M., Mays, D. C. és mtsai: CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastrooesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms. Aliment. Pharmacol. Ther., 2003, 17 , 1521–1528.

    Mays D. C. , 'CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastrooesophageal reflux disease: variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms ' (2003 ) 17 Aliment. Pharmacol. Ther. : 1521 -1528.

    • Search Google Scholar
  • Peghini, P. L., Katz, P. O., Bracy, N. A. és mtsai: Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am. J. Gastroenterol., 1998, 93 , 763–767.

    Bracy N. A. , 'Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors ' (1998 ) 93 Am. J. Gastroenterol. : 763 -767.

    • Search Google Scholar
  • Ours, T. M., Fackler, W. K., Richter, J. E. és mtsai: Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am. J. Gastroenterol., 2003, 98 , 545–550.

    Richter J. E. , 'Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure ' (2003 ) 98 Am. J. Gastroenterol. : 545 -550.

    • Search Google Scholar
  • Orr, W. C., Harnish, M. J.: The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity. Aliment. Pharmacol. Ther., 2003, 17 , 1553–1558.

    Harnish M. J. , 'The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity ' (2003 ) 17 Aliment. Pharmacol. Ther. : 1553 -1558.

    • Search Google Scholar
  • Verdu, E. F., Armstrong, D., Fraser, R. és mtsai: Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut, 1995, 36 , 539–543.

    Fraser R. , 'Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole ' (1995 ) 36 Gut : 539 -543.

    • Search Google Scholar
  • Vigneri, S., Termini, R., Savarino, V. és mtsai: Review article: is Helicobacter pylori status relevant to the management of GORD? Aliment. Pharmacol. Ther., 2000, 14 (Suppl. 3) , 31–42.

    Savarino V. , 'Review article: is Helicobacter pylori status relevant to the management of GORD? ' (2000 ) 14 Aliment. Pharmacol. Ther. : 31 -42.

    • Search Google Scholar
  • Sampliner, R. E.: Effect of up to 3 years of high-dose lansoprazole on Barrett’s esophagus. Am. J. Gastroenterol., 1994, 89 , 1844–1848.

    Sampliner R. E. , 'Effect of up to 3 years of high-dose lansoprazole on Barrett’s esophagus ' (1994 ) 89 Am. J. Gastroenterol. : 1844 -1848.

    • Search Google Scholar
  • Malesci, A., Savarino, V., Zentilin, P. és mtsai: Partial regression of Barrett’s esophagus by long-term therapy with omeprazole. Gastrointest. Endosc., 1996, 44 , 700–705.

    Zentilin P. , 'Partial regression of Barrett’s esophagus by long-term therapy with omeprazole ' (1996 ) 44 Gastrointest. Endosc. : 700 -705.

    • Search Google Scholar
  • Bredenoord, A. J., Weusten, B. L., Smout, A. J.: Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut, 2005, 54 , 1810–1817.

    Smout A. J. , 'Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring ' (2005 ) 54 Gut : 1810 -1817.

    • Search Google Scholar
  • Zerbib, F., Roman, S., Ropert, A. és mtsai: Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am. J. Gastroenterol., 2006, 101 , 1956–1963.

    Ropert A. , 'Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy ' (2006 ) 101 Am. J. Gastroenterol. : 1956 -1963.

    • Search Google Scholar
  • Charbel, S., Khandwala, F., Vaezi, M. F.: The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am. J. Gastroenterol., 2005, 100 , 283–289.

    Vaezi M. F. , 'The role of esophageal pH monitoring in symptomatic patients on PPI therapy ' (2005 ) 100 Am. J. Gastroenterol. : 283 -289.

    • Search Google Scholar
  • Fouad, Y. M., Katz, P. O., Castell, D. O.: Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. Aliment. Pharmacol. Ther., 1999, 13 , 1467–1471.

    Castell D. O. , 'Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors ' (1999 ) 13 Aliment. Pharmacol. Ther. : 1467 -1471.

    • Search Google Scholar
  • Trivedi, A., Long, J. D.: Heartburn refractory to proton-pump inhibitors. Curr. Treat. Options Gastroenterol., 2007, 10 , 47–56.

    Long J. D. , 'Heartburn refractory to proton-pump inhibitors ' (2007 ) 10 Curr. Treat. Options Gastroenterol. : 47 -56.

    • Search Google Scholar
  • Savarino, V., Savarino, E., Dulbecco, P.: Proton pump inhibitor failure: why does it occur and how can it be managed? Digestion, 2006, 73 , 215–217.

    Dulbecco P. , 'Proton pump inhibitor failure: why does it occur and how can it be managed? ' (2006 ) 73 Digestion : 215 -217.

    • Search Google Scholar
  • Mainie, I., Castell, D. O.: Do we need to rethink fundoplication for patients who have failed proton-pump-inhibitor therapy? Nat. Clin. Pract. Gastroenterol. Hepatol., 2006, 3 , 2–3.

    Castell D. O. , 'Do we need to rethink fundoplication for patients who have failed proton-pump-inhibitor therapy? ' (2006 ) 3 Nat. Clin. Pract. Gastroenterol. Hepatol. : 2 -3.

    • Search Google Scholar